Shree Parmatama Chand Bhandari Hospital And Research Centre Profile
Key Indicators
- Authorised Capital ₹ 3.70 M
as on 16-11-2024
- Paid Up Capital ₹ 3.68 M
as on 16-11-2024
- Company Age 27 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 3.15 M
as on 16-11-2024
- Revenue 22.54%
(FY 2023)
- Profit -76.92%
(FY 2023)
- Ebitda -78.52%
(FY 2023)
- Net Worth 60.43%
(FY 2023)
- Total Assets 51.16%
(FY 2023)
About Shree Parmatama Chand Bhandari Hospital And Research Centre
The Corporate was formerly known as Shree Parmatama Chand Bhandari Hospital And Research Centre Pvt.Ltd. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.70 M and a paid-up capital of Rs 3.68 M.
The company has closed loans amounting to ₹3.15 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Shashi Bhandari, Sahil Bhandari, and Surendra Bhandari serve as directors at the Company.
- CIN/LLPIN
U85110RJ1997NPL013630
- Company No.
013630
- Company Classification
Private Not For Profit Company
- Incorporation Date
25 Apr 1997
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Jaipur
Industry
Company Details
- Location
Jodhpur, Rajasthan, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shree Parmatama Chand Bhandari Hospital And Research Centre?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Shashi Bhandari | Director | 25-Apr-1997 | Current |
Sahil Bhandari | Director | 14-Feb-2022 | Current |
Surendra Bhandari | Director | 25-Apr-1997 | Current |
Financial Performance of Shree Parmatama Chand Bhandari Hospital And Research Centre.
Shree Parmatama Chand Bhandari Hospital And Research Centre, for the financial year ended 2023, experienced significant growth in revenue, with a 22.54% increase. The company also saw a substantial fall in profitability, with a 76.92% decrease in profit. The company's net worth Soared by an impressive increase of 60.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Shree Parmatama Chand Bhandari Hospital And Research Centre?
In 2023, Shree Parmatama Chand Bhandari Hospital And Research Centre had a promoter holding of 97.96% and a public holding of 2.04%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Marwar Institute For Health & EducationActive 11 years 9 months
Shashi Bhandari and Sahil Bhandari are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Syndicate Bank Creation Date: 04 Sep 2015 | ₹0.95 M | Satisfied |
Syndicate Bank Creation Date: 26 May 2004 | ₹2.00 M | Satisfied |
Syndicate Bank Creation Date: 25 Jun 2002 | ₹0.20 M | Satisfied |
How Many Employees Work at Shree Parmatama Chand Bhandari Hospital And Research Centre?
Unlock and access historical data on people associated with Shree Parmatama Chand Bhandari Hospital And Research Centre, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shree Parmatama Chand Bhandari Hospital And Research Centre, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shree Parmatama Chand Bhandari Hospital And Research Centre's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.